Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Dementia and Geriatric Cognitive Disorders|September 7, 2006
Longitudinal changes of cerebral glucose metabolism in semantic dementiaJ Diehl-Schmid, T Grimmer, A Drzezga, et al.
Neurobiology of Aging|February 2, 2006
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-studyJ Diehl-Schmid, T Grimmer, A Drzezga, et al.
Journal of Geriatric Psychiatry and Neurology|February 1, 2005
Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosisJ Diehl, A U Monsch, C Aebi, et al.
Neurology|January 12, 2005
Cerebral glucose metabolism in patients with AD and different APOE genotypesA Drzezga, M Riemenschneider, B Strassner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 20, 2006
Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomographyR Perneczky, A Drzezga, J Diehl-Schmid, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar DegenerationM Ortner, O Goldhardt, J Diehl-Schmid, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Neurology|April 3, 2009
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer diseaseA Drzezga, T Grimmer, G Henriksen, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic ImpactF G Boess, M A Scelsi, T Grimmer, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) InvestigatorsF Jessen, M G Kramberger, D Angioni, et al.
Pageof 2